Bersi named 2025 Young Innovator in Cellular and Molecular Bioengineering

Matthew Bersi has been recognized by the Biomedical Engineering Society as an innovative and impactful junior faculty member in bioengineering

Shawn Ballard 
Matthew Bersi (right) works with a student in the Soft Tissue Biomechanics Lab. (Photo: Whitney Curtis)
Matthew Bersi (right) works with a student in the Soft Tissue Biomechanics Lab. (Photo: Whitney Curtis)

Matthew Bersi, assistant professor of mechanical engineering & materials science in the McKelvey School of Engineering at Washington University in St. Louis, has been named a 2025 Young Innovator in Cellular and Molecular Bioengineering by the Biomedical Engineering Society (BMES). This recognition is given to junior faculty who have made innovative and impactful contributions to the bioengineering field. 

Bersi’s research focuses on developing experimental and computational methods to explore how biomechanics and inflammation interact in soft tissues. His primary area of application is cardiovascular disease, where he investigates the immune system's role in conditions such as hypertension, cardiac fibrosis and vascular injury.

This recent award recognizes Bersi’s work investigating the influence of fat, or adipose tissue, on fibroblast mechanobiology and fibrosis. His innovative approaches also have broader implications for understanding biomechanical regulation in various injuries and diseases across different tissues and organs. For example, recent work from his laboratory has been focused on remodeling of the female reproductive system throughout pregnancy and postpartum healing.

As part of the award, Bersi will contribute a research article to the 2025 Young Innovators Special Issue of the Cellular and Molecular Bioengineering journal. He will also present his work at a special session of the 2025 Fall BMES Conference.

Click on the topics below for more stories in those areas

Back to News